Global Orphan Drugs CDMOs Market Analysis by Size, Share, Growth, Trends, Demand and Investments by 2027
Orphan drugs are designed to address various medical conditions thus impacting a relatively small population, typically fewer than 200,000 individuals in the United States or a similarly low prevalence in other countries. Orphan Drugs CDMOs offer a broad range of services, including drug formulation, process development, clinical trial materials manufacturing, and commercial-scale production. They work closely with pharmaceutical companies and biotech firms to bring orphan drugs to the global market. Orphan Drugs CDMO Market: Addressing Unfulfilled Medical Needs for Rare Diseases The Orphan Drugs Contract Development and Manufacturing Organizations (CDMOs) market is estimated for a lucrative growth due to heavy investments in therapies for rare diseases. This growth is being triggered by the global orphan drug CDMO market, which is motivated by unfulfilled medical needs and regulatory incentives, thus making it an attractive market for CDMOs. For instance, In February...